![James Garegnani](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James Garegnani
Corporate Officer/Principal at Gavis Pharmaceuticals LLC
Profile
James Garegnani is currently working as the Director-Product Development at Gavis Pharmaceuticals LLC since 2010.
He holds an MBA from Southern Illinois University and an undergraduate degree from Monmouth College.
James Garegnani active positions
Companies | Position | Start |
---|---|---|
Gavis Pharmaceuticals LLC
![]() Gavis Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology GAVIS Pharmaceuticals LLC is a marketer, distributor, wholesaler, and business customer specializing in customer service to the pharmaceutical industry. Its products include dexmethylphenidate hydrochloride, dextroamphetamine sulfate, dextroamphetamine sulfate, methylphenidate hydrochloride, misoprostol, nifedipine, nitrofurantoin, nystatin, phenelzine sulfate, and other related products. The company was founded was founded by Veerappan Sellappan Subramanian in July 2008 and is headquartered in Somerset, NJ. | Corporate Officer/Principal | 31/07/2010 |
Training of James Garegnani
Monmouth College | Undergraduate Degree |
Southern Illinois University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Gavis Pharmaceuticals LLC
![]() Gavis Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology GAVIS Pharmaceuticals LLC is a marketer, distributor, wholesaler, and business customer specializing in customer service to the pharmaceutical industry. Its products include dexmethylphenidate hydrochloride, dextroamphetamine sulfate, dextroamphetamine sulfate, methylphenidate hydrochloride, misoprostol, nifedipine, nitrofurantoin, nystatin, phenelzine sulfate, and other related products. The company was founded was founded by Veerappan Sellappan Subramanian in July 2008 and is headquartered in Somerset, NJ. | Health Technology |
- Stock Market
- Insiders
- James Garegnani